Lerman Bradley E 4
4 · Medtronic plc · Filed Sep 1, 2021
Insider Transaction Report
Form 4
Lerman Bradley E
SVP General Counsel & Corp Sec
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2021-08-31−50,775→ 0 totalExercise: $74.84Exp: 2025-01-27→ Ordinary Shares (50,775 underlying) - Exercise/Conversion
Ordinary Shares
2021-08-31$74.84/sh+50,775$3,800,001→ 99,538 total - Sale
Ordinary Shares
2021-08-31$134.17/sh−50,775$6,812,482→ 48,763 total
Footnotes (3)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- [F2]This option becomes exercisable on June 29, 2018, subject to Medtronic's achievement of a pre-specified cash Earnings Per Share Growth Rate for fiscal years 2016 through 2018.
- [F3]This date was previously reported incorrectly as 7/28/2024.